Scribd
Upload
83 views7 pages

Market Analysis of Medicine Segment in Healthcare Industry

The document analyzes the market for medicines in India's growing healthcare industry. It finds that the overall Indian healthcare market is US$65 billion and growing at 18% annually, faster than any other country. Within this market, pharmaceuticals make up 65% and have seen the rise of large domestic companies as well as opportunities for generics, clinical trials and research partnerships. The medicine segment is projected to reach US$4.5-5 billion by focusing on rural healthcare needs and new drug discovery.

Uploaded by

Jatin Kshyp
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
83 views7 pages

Market Analysis of Medicine Segment in Healthcare Industry

The document analyzes the market for medicines in India's growing healthcare industry. It finds that the overall Indian healthcare market is US$65 billion and growing at 18% annually, faster than any other country. Within this market, pharmaceuticals make up 65% and have seen the rise of large domestic companies as well as opportunities for generics, clinical trials and research partnerships. The medicine segment is projected to reach US$4.5-5 billion by focusing on rural healthcare needs and new drug discovery.

Uploaded by

Jatin Kshyp
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 7

REPORT

ON

MARKET ANALYSIS OF
MEDICINE SEGMENT IN
HEALTHCARE
INDUSTRY

Made by: jatin kashyap


College : shaheed sukhdev college of business
studies
Submitted : sir pankaj gupta, CEO
(MERAMEDICARE.COM)

Introduction to healthcare industry


In India
India a country with a population of more than
people is
growing fast in other fields as well other than its population size .
As a result the health care industry in India has also seen a
significant rise in last decade . some stats are listed below from
past decade:
Indian Economy growing at 8%+ despite global economic
meltdown
Size of the Indian Healthcare Industry - US$35 billion
contributes over 5% of GDP and offers employment to over
4% population
Indian Healthcare Industry Growing at Rapid pace of 18%+ fastest in the world

600,000 practicing physicians


15,000 hospitals
875,000 hospital beds
737,000 nurses
170 medical colleges
350,000 retail pharmacies
18,000 new doctors every year
50,000 pathology laboratories

There are a lot of business opportunities available In this sector in


india. Our country has become an attractive destination for
medical tourism , clinical studies and research & development
programs. There is a massive scope of growth and expansion.

Healthcare has become one of India's largest sectors - both in


terms of revenue and employment. The industry comprises
hospitals, medical devices, clinical trials, outsourcing,
telemedicine, medical tourism, health insurance and medical
equipment. The Indian healthcare industry is growing at a
tremendous pace due to its strengthening coverage, services and
increasing expenditure by public as well private players .

Government is also taking initiative to expand health care


industry . India's universal health plan that aims to offer
guaranteed benefits to a sixth of the world's population will cost
an estimated Rs 1.6 trillion (US$ 25.73 billion) over the next four
years. The Competition Commission of India (CCI) in its meeting
has approved the proposed merger between Sun Pharma and
Ranbaxy, subject to the parties inter alia carrying out the
divestiture of their products relating to seven relevant markets for
formulations. And also Generic drug maker Mylan Inc and the USbased Abbott Industries have received the CCIs nod to proceed
with their merger.

Market Size in India


According to estimates, the overall Indian health care market
today is US$ 65 billion, of which the hospital supplies and health
care equipment segment is believed to be around US$ 4.5-5
million. Health care delivery, which includes hospitals, nursing
homes and diagnostics centres, and pharmaceuticals, constitutes
65 per cent of the overall market.
Indian healthcare industry is the second largest service sector
employers in the country. It provide jobs for 4.5mn people directly
or indirectly.

Overall the number of transactions in the healthcare space is


going to grow as companies are seeking growth capital. The
average investment size by private equity funds in healthcare
chains has increased to US$ 20-30 million which was around US$
5-15 million.

The Indian medical tourism industry is pegged at US$ 1 billion per


annum, growing at around 18 per cent and is expected to touch
US$ 2 billion by 2016.
There is a significant scope for enhancing healthcare services
considering that healthcare spending as a percentage of GDP is
rising. Rural India, which accounts for over 70 per cent of the
population, is set to emerge as a potential demand source. Only
three per cent of specialist physicians cater to rural demand.

PHARMACEUTICAL INDUSTRY
The Indian pharmaceutical industry is the world's secondlargest by volume.
The first pharmaceutical company was Bengal
Chemicals and Pharmaceutical Works, which still exists today

as one of 5 government-owned drug manufacturers, formed


in Calcutta in 1903.
For the next 60 years, most of the drugs in India were
imported by multinationals either in fully formulated or bulk
form.
In fy 2009-2010 Bio-Pharmaceutical was the biggest
contributor generating 60 percent of the industry's growth at
Rs. 8,829/- crore, followed by bio-services at Rs.2,639/- crore
and bio-agri at Rs.1,936 crore.

A list is given below of top 10 companies in pharmaceutical


industry with their growth rate and revenues as of 2014.

Opportunities in pharma industry


Indian companies are adapting to the new environment.
Firms have made their ways into the global market,
By researching generic competitors to patented drugs
Following up with litigation to challenge the patent.
Those who can afford it, have set their sights on an
even higher goal: new molecule discovery.
Initial investment is huge, but companies are promised
hefty profit margins & recognition globally.

Local firms have been investing money into their R&D


programs or have formed alliances.

Bibliography
Wikipedia
india pharma by 2020 (report by mckensey )
google.com

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy